Evidence map›Paper›PMID 31147852›Full record

ArticleCellular and molecular neurobiology2019

Pretreatment of Grape Seed Proanthocyanidin Extract Exerts Neuroprotective Effect in Murine Model of Neonatal Hypoxic-ischemic Brain Injury by Its Antiapoptotic Property.

Xing Tu, Mengxia Wang, Yilin Liu, Wenyan Zhao, Xuxin Ren, Yuanjun Li, Hongqing Liu, Ziting Gu, Hui Jia, Jing Liu and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Nutrients · 2022
    Article
  7. Antioxidants (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Grape (Foods (Basel, Switzerland) · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Xing TuSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China.ORCID http://orcid.org/0000-0003-4354-6698
Mengxia WangIntensive Care Unit, Guangdong No. 2 Provincial People's Hospital, Guangzhou, 510317, People's Republic of China.
Yilin LiuSchool of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China.
Wenyan ZhaoSchool of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China.
Xuxin RenSchool of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China.
Yuanjun LiSchool of Clinical Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China.
Hongqing LiuSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China.
Ziting GuSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China.
Hui JiaSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China.
Jing LiuSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China.
Guoying LiSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China. gzlgying820@sina.com.
Li LuoSchool of Biosciences & Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, People's Republic of China. josephluoli@hotmail.com.
Guangdong Pharmaceutical University · CNGuangdong Provincial People's Hospital · CN

Funding

Natural Science Foundation of Guangdong Province 2018A030313579the Guangdong Province Innovation and Entrepreneurship Training Program for University Students grant no. 201710573046the Science Foundation of Guangdong No. 2 Provincial People's Hospital for Youth grant no. YQ2017-001
6 · The paper itself

Abstract

Grape seed proanthocyanidin extract (GSPE), an active component extracted from the grape, has been reported to demonstrate antioxidant, anti-inflammatory, anticancer, and antiapoptosis effects. However, little is known about the role of GSPE on neonatal hypoxic-ischemic (HI) brain injury. The aim of this study was to evaluate the neuroprotective effect of GSPE pretreatment on neonatal HI brain injury in mice. A modified Rice-Vannucci method was performed to induce neonatal HI brain injury in the 7-day-old mouse pups pretreated with GSPE or vehicle. The infarct volumes were determined by TTC staining. TUNEL staining was used to detect cells apoptosis, and the expressions of apoptosis-related proteins: bax, bcl2, and cleaved caspase-3 were assayed by Western blot. Behavioral tests were also conducted to assess the functional recovery after injury. We showed that the brain damage and neurobehavioral outcomes improvement was observed in GSPE pretreated group. GSPE was proved to suppress apoptosis through inhibition of bax and cleaved caspase-3 expression. It demonstrates that GSPE could alleviate brain damage maybe through its antiapoptotic activity in a neonatal HI brain injury model, and GSPE has the potential to be a new drug for effective prevention of this disorder.

Indexed as

ApoptosisAnimalsAnimals, NewbornBehavior, AnimalBrain InjuriesDisease Models, AnimalGrape Seed ExtractHypoxia-Ischemia, BrainMice, Inbred C57BLNeuronsNeuroprotective AgentsPlant ExtractsProanthocyanidinsGrape Seed ExtractGrape Seed ProanthocyanidinsNeuroprotective AgentsPlant ExtractsProanthocyanidinsApoptosisGSPENeonatal hypoxic-ischemic brain injuryNeuroprotection

Identifiers

PMID31147852
PMCPMC11457837
OpenAlexW2947802143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.